Dr Sara Farrah Heuss

Postdoctoral Researcher
Research Focus

C-Met is a receptor tyrosine kinase, overexpressed in pancreatic cancer. Studies published by our group have shown that c-Met triggers the activation of oncogenic signals such as ERK1/2, STAT3 and Rac1 from endosomes. My work focuses on c-Met signalling on endosomes in pancreatic cancer, and to evaluate how it can be exploited to benefit pancreatic cancer patients.

Supervisor:
Dr St├ęphanie Kermorgant
Upcoming Events
  1. The London Pancreas Workshop 2020

    May 1 @ 9:30 am - 4:30 pm
  2. 2020 Circulating Cancer Biomarker Symposium

    May 4 @ 9:00 am - 5:30 pm
© 2013 ~ 2020 Cancer Research UK Barts Centre